Atorvastatin Versus Vitamin E in Treatment of Non-alcoholic Fatty Liver Disease
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.
Also called NCT01720719
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 120 participants
- Sponsor
- Registry
-
NCT01720719
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT01720719. Randomized; no masking; primary purpose treatment. Start 2013-05 (registry gives no type); primary completion 2016-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Atorvastatin Versus Vitamin E in Treatment of Non-alcoholic Fatty Liver Disease
- Condition
- Fatty Liver
- Condition
- Dyslipidemias
- Condition
- Diabetes Mellitus
- Intervention (Drug)
- atorvastatin
- Intervention (Drug)
- Vitamin E
- Lead sponsor
- Xin Gao
- Collaborator
- Pfizer
Record details
- Record id
cardio:ct-nct01720719- Content hash
30a414b9dfdfd4399c35176f94ef59aadebf0b964806fce784325aacb1bef4a1